- Home
- EDIT vs BMBL Comparison
EDIT vs BMBL Comparison
Compare EDIT & BMBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDIT | BMBL |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 432.8M | 417.4M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | EDIT | BMBL |
|---|---|---|
| Price | $2.91 | $2.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 14 |
| Target Price | ★ $6.10 | $3.79 |
| AVG Volume (30 Days) | ★ 2.5M | 2.0M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $31,937,000.00 | ★ $965,658,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 132.64 | N/A |
| 52 Week Low | $1.66 | $2.44 |
| 52 Week High | $4.33 | $5.96 |
Technical Indicators
Market Signals| Indicator | EDIT | BMBL |
|---|---|---|
| Relative Strength Index (RSI) | 56.18 | 37.78 |
| Support Level | $2.46 | N/A |
| Resistance Level | $3.18 | $3.16 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 70.14 | 17.71 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary gene editing platform based on CRISPR technology and continues to expand its capabilities. CRISPR uses a protein-RNA complex composed of an enzyme, including either Cas9 (CRISPR-associated protein 9) or Cas12a (CRISPR from Prevotella and Francisella 1, also known as Cpf1). The company has a single operating segment, which is the business of developing and commercializing gene editing technology.
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company operates as one operating segment with revenue derived in the form of recurring subscriptions and in-app purchases. The company operates in USA, which derives maximum revenue; and Rest of the World.